Share of tuberculosis patients with HIV in Rwanda
Rwanda: Share of tuberculosis patients with HIV was 13.0% in 2024. ▼ Falling
Share of tuberculosis patients with HIV in Rwanda, 2000–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
In 2024, share of tuberculosis patients with hiv in Rwanda stood at 13.0%.
The figure is up 8.3% on the previous year and down 48.0% over ten years.
Over the whole period, share of tuberculosis patients with hiv in Rwanda peaked at 53.0% in 2000 and was at its lowest, 12.0%, in 2023.
That places Rwanda 36th out of 179 countries with data for 2024, putting it in the top quarter.
The long-run direction has been consistently falling across the 25 years of available data.
Share of tuberculosis patients with HIV in Rwanda, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 53.0% | — |
| 2001 | 47.0% | -11.3% |
| 2002 | 43.0% | -8.5% |
| 2003 | 40.0% | -7.0% |
| 2004 | 39.0% | -2.5% |
| 2005 | 45.0% | +15.4% |
| 2006 | 41.0% | -8.9% |
| 2007 | 37.0% | -9.8% |
| 2008 | 34.0% | -8.1% |
| 2009 | 34.0% | +0.0% |
| 2010 | 32.0% | -5.9% |
| 2011 | 28.0% | -12.5% |
| 2012 | 26.0% | -7.1% |
| 2013 | 25.0% | -3.8% |
| 2014 | 25.0% | +0.0% |
| 2015 | 27.0% | +8.0% |
| 2016 | 21.0% | -22.2% |
| 2017 | 22.0% | +4.8% |
| 2018 | 21.0% | -4.5% |
| 2019 | 21.0% | +0.0% |
| 2020 | 19.0% | -9.5% |
| 2021 | 16.0% | -15.8% |
| 2022 | 13.0% | -18.8% |
| 2023 | 12.0% | -7.7% |
| 2024 | 13.0% | +8.3% |
Rwanda compared with similar countries
- Rwanda's 13.0% is above the median for low income countries, which is 6.5%, 2.0× the median. (24 countries reporting)
- Rwanda's 13.0% is above the median for Sub-Saharan Africa, which is 12.0%, 1.1× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.3% | 34.0% | 53.0% | 10 |
| 2010s | 24.8% | 21.0% | 32.0% | 10 |
| 2020s | 14.6% | 12.0% | 19.0% | 5 |
Countries ranked near Rwanda
More health data for Rwanda
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.891 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 860.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,738 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate 0.9441 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.065 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9697 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is share of tuberculosis patients with hiv in Rwanda?
- Share of tuberculosis patients with hiv in Rwanda was 13.0% in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest share of tuberculosis patients with hiv recorded in Rwanda?
- The highest recorded value was 53.0% in 2000.
- What is the lowest share of tuberculosis patients with hiv recorded in Rwanda?
- The lowest recorded value was 12.0% in 2023.
- How does Rwanda rank for share of tuberculosis patients with hiv?
- Rwanda ranks 36th out of 179 countries with data for 2024.
- Is share of tuberculosis patients with hiv rising or falling in Rwanda?
- Over the last ten years it is down 48.0%. The long-run trend across the full record is falling.
- Where does this Rwanda data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Share of tuberculosis patients with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The estimated share of people with tuberculosis who also have HIV.